Experiments on the HCRT/ataxin-3 narcolepsy mouse model demonstrated that intracerebroventricular (ICV) injections of HCRT-1 can compensate for HCRT cell loss and reverse most of the narcolepsy symptoms including cataplexy [14]. The gene discussed is ATXN3; the disease is narcolepsy.